A Message from FSP Regarding COVID-19













Pathology Today

newsletter

Pathology Today, February 4, 2015

CDC installing cameras in labs in agency-wide safety push
Reuters
The U.S. Centers for Disease Control and Prevention has introduced camera monitoring of workers in its highest-level biosafety laboratories as it seeks to restore public faith in its procedures after a series of mishaps, agency officials tell Reuters. 

Read More

newsletter

Pathology Today, January 22, 2015

Top legal minds against FDA's proposal to regulate lab tests
RAPS
A new legal whitepaper authored by two of America's most prominent lawyers argues that the U.S. Food and Drug Administration's plan to regulate lab developed tests (LDTs) more similarly to traditional medical devices lacks legal justification and is therefore unlawful. 

Read More

newsletter

Pathology Today, January 8, 2015

UnitedHealthcare pushes back start date for making claims-payment decisions
Dark Daily
Physicians, pathologists, and clinical laboratories in Florida got a late Christmas present. UnitedHealthcare postponed the date when its medical laboratory benefit-management pilot program in Florida, administered by BeaconLBS, would affect claims payments. This was welcome news, because, beginning Jan. 1, if physicians serving UHC patients had failed to use the BeaconLBS system to obtain pre-notification or pre-authorization for 82 medical laboratory tests, the physicians or labs performing the tests would not be paid by UHC—nor could clinical labs and pathology groups in the UHC provider network bill patients for these tests. 

Read More

newsletter

Pathology Today, December 23, 2014

Scientists identify 'high-priority' chemicals that may cause breast cancer
Medical News Today
From May 14: An estimated 12.4 percent of women born in the U.S. today will develop breast cancer at some point during their lives. Past research has indicated that exposure to some chemicals may increase the risk of breast cancer. Now, a new study has identified 17 "high-priority" chemicals women should avoid in order to reduce such risk and demonstrates how their presence can be detected.

Read More

newsletter

Pathology Today, December 10, 2014

Study spotlights high prices of medical lab tests charged by California hospitals
Dark Daily
Clinical laboratories owned by hospitals and health systems should take note of a public study of hospital laboratory test prices that was conducted by researchers at the University of California at San Francisco. It was published this summer and showed a remarkable range of prices for medical laboratory tests charged by California hospitals. How about a charge of $10,169 for a routine blood cholesterol test? This was one finding a study discussed in the August 2014 issue of the British Medical Journal Open blog. 

Read More

newsletter

Pathology Today, November 26, 2014

Real-time genome sequencing helps control hospital outbreak
Medical Xpress
Pioneering use of whole genome sequencing in real time to help control a hospital outbreak is reported in an article published in the open access journal Genome Medicine. The research corroborates the use of the technique as a rapid and cost-effective way of tracking and controlling the spread of drug-resistant hospital pathogens.

Read More

newsletter

Pathology Today, November 12, 2014

New business model for medical billing companies
By Mick Raich
The key in any industry is to make a margin — that difference between cost and revenue, the part you get to take home every two weeks so little Tommy can have a new iPad. As change takes place, companies that fall short of this margin inevitably fail. They may leverage themselves with loans or lower their costs by decreasing output, but sooner or later the bills have to be paid. In the medical billing industry, companies have literally searched far and wide for this margin. Over the past 10 years we have seen considerable use of Business Process Outsourcing firms that handle various parts of the billing process overseas.  

Read More

newsletter

Pathology Today, October 29, 2014

'Genetic Testing Handbook' provides pathologists, lab managers with comprehensive reference for clinical genome and exome sequencing
Dark Daily
Clinical use of gene sequencing information has advanced to the point where a team of genetic experts has compiled and issued the Genetic Testing Handbook. The goal of the clinical genome and exome sequencing (CGES) handbook is to provide clinicians — including pathologists and clinical laboratory scientists — with a useful reference tool. 

Read More

newsletter

Pathology Today, October 15, 2014

You are invited to FSP's 41st Annual Anatomic Pathology Conference
FSP
It will be another Sensational program featuring presentations on cutting edge pathology topics. Click here for more information and to register. 

Read More

newsletter

Pathology Today, October 1, 2014

To find patients at highest risk, hospitals combine consumer data with clinical information
Dark Daily
Big data is all the rage in healthcare these days. However, one interesting development in this field is how hospitals are integrating consumer data with clinical data to identify patients at high risk. For example, if the post-surgical heart patient buys a package of cigarettes, some hospitals say they want to know. This is a trend with interesting implications for clinical laboratories. 

Read More

Pages